Treatment of common side effects of Maribavir/Yitazhi

Maribavir (Maribavir), as a first-line anti-cytomegalovirus (CMV) infection drug, is widely used in organ transplantation and patients with low immune function, showing good efficacy and controllable safety. However, any drug may have adverse reactions in clinical application, posing challenges to patient safety and treatment compliance. Therefore, understanding common side effects and strategies to deal with them is crucial to optimizing treatment.

Clinical observations show that the most common adverse reactions of maribavir include digestive system reactions, hematological abnormalities, mild neurological symptoms and increased risk of virus-related infections. Among them, mild nausea, diarrhea or gastrointestinal discomfort are more common, and most patients can be relieved by taking the medicine in divided doses or after meals. For patients who experience headache, dizziness or fatigue, the administration time or dose can be adjusted appropriately while monitoring changes in symptoms. Hematological abnormalities, such as mild platelet or neutropenia, usually do not require discontinuation of treatment, and treatment continuity can be maintained through laboratory monitoring and symptomatic management. Rare serious adverse events include elevated liver function or allergic reactions, requiring discontinuation or dose adjustment under physician guidance.

Patients should undergo regular blood routine, liver and kidney function and virological monitoring during the use of maribavivir in order to detect side effects early. Symptomatic management strategies include drug dose adjustment, supportive care, and symptom management. For example, mild diarrhea or gastrointestinal discomfort can be relieved through rehydration and probiotic auxiliary treatment; mild dizziness or fatigue can be managed by ensuring rest and taking medication in divided doses. For patients with severe or persistent discomfort, discontinuation of medication or substitution of other anti-CMV regimens should be considered under the guidance of a professional physician. Through standardized monitoring and management, most side effects can be effectively controlled without affecting the overall treatment effect.

Reference materials:https://www.livtencity.com/